A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.
about
Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver MyofibroblastsVitamin D and the Epithelial to Mesenchymal TransitionHepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepEndocrine causes of nonalcoholic fatty liver diseaseRelationship of structure and function of DNA-binding domain in vitamin D receptorNuclear Receptors, RXR, and the Big BangThe role of nuclear hormone receptors in cutaneous wound repairRemodelling the extracellular matrix in development and diseaseContributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancerHepatic actions of vitamin D receptor ligands: a sunshine option for chronic liver disease?Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?Vitamin D: a new player in non-alcoholic fatty liver disease?p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver CancerPromising therapies for treatment of nonalcoholic steatohepatitis.Vitamin D and adipose tissue-more than storageThe multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells.Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes.Genome-wide (over)view on the actions of vitamin DHypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver diseaseMouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype.Vitamin D and the RNA transcriptome: more than mRNA regulation.MKL1 defines the H3K4Me3 landscape for NF-κB dependent inflammatory response.Overexpression of GSN could decrease inflammation and apoptosis in EAE and may enhance vitamin D therapy on EAE/MSLow Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients.1,25-(OH)2D3 and its analogue BXL-628 inhibit high glucose-induced activation of RhoA/ROCK pathway in HK-2 cells.Relationship between Nonalcoholic Fatty Liver Disease and Vitamin D Nutritional Status in Extreme Obesity.Stromal reengineering to treat pancreas cancerVitamin D in inflammatory diseases.Fibroblast heterogeneity in the cancer wound.VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells.Expression of the vitamin D receptor in skeletal muscle: are we there yet?Vitamin D modulates biliary fibrosis in ABCB4-deficient mice.Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.Interactions between vitamin D and IGF-I: from physiology to clinical practice.The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers.Pathobiology of liver fibrosis: a translational success storyVitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential.Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.Vitamin D deficiency in chronic liver disease.Primary 1,25-dihydroxyvitamin D3 response of the interleukin 8 gene cluster in human monocyte- and macrophage-like cells.
P2860
Q26745566-CA158E34-6917-494F-8182-3A7A88073331Q26765878-6957A142-8C69-43F3-AF90-0684A651D805Q26771518-05F15228-B6FA-4BE0-B0B4-580BC2382F9EQ26780254-23388867-4FCE-48D6-907D-ADD6167FF7B0Q26801309-6043820A-C848-4BA9-909C-E5F0E29864A4Q26821789-2BB1D8F0-97CC-450A-86DA-EA061081726DQ26859112-4B4AFBD2-23C0-4FAD-85DF-9B38751C0B80Q26864798-65E43AAE-FD8C-4FDF-BCC6-E577EDFA5596Q26992106-BABF76F0-4375-4004-B737-1ACF10A2E9D8Q27025390-9779D448-AB59-4A4C-B1D7-B0B92929B620Q28066233-ABED5A00-A513-40C4-8FA3-3184EC30DD4EQ28081391-6DFB5449-500D-4B10-9F28-D1173E2246C7Q29144909-6362FB46-319F-4CD7-B4DD-5424FDB5F79FQ30248578-DCBCADA7-F321-4FDD-A423-1ECAB01BD0ACQ30364529-BDCAA470-5E7F-40FF-8525-F5844A53A88DQ30388273-0CDFA221-025C-44D9-9668-85520ED53753Q31159857-B3F5C1C1-2DCD-4CEC-8F89-9C8D29B5DABBQ33569318-C4ABA769-126F-4568-A2AC-73014B2438FFQ33573989-A05ECAD2-5C97-4A15-857E-B1C49E87DEA8Q33610663-D08915DF-4F6F-4685-9C74-7E42409DC8E5Q33646923-21416C74-4EBD-4923-8E3B-6D0F70D33074Q33670807-C7F8F094-D7DC-47CB-80FE-2D22E10E1682Q33674277-9F3268AD-2A69-41BE-9344-45CA324DC40DQ33701184-B11454DB-0FF3-4D67-9FCA-FDA490B7C27CQ33723777-7F6173AE-9E4E-4B40-8B4C-4ED7039373FDQ33823038-1D04D7C8-1F47-4211-83CB-36DC88F1D64AQ33827708-742A1F25-2F66-45A3-9A23-C7F2C152FD61Q33833563-7C2CF80D-69AA-46C4-8FD8-5632F2A0FF44Q33964324-047B8B93-AAC0-434F-8262-045861540198Q34053767-FBEE3227-2632-4EED-99E7-DC6536EE5C5FQ34068341-84E929B6-114C-42F7-AECB-DF86C10648E7Q34104332-6A332814-8037-4A33-9E5C-ED86C3B11925Q34253198-60905E21-A261-4A82-B853-8C0AFA1F32CFQ34352477-F2EC53C2-E9C0-4CC6-A521-185B6FCF0861Q34396348-FB969443-3F5B-4A63-AC7B-8535EF2C5403Q34462733-DC0F84E0-684E-4441-A1AB-7C9EBFF0C9ECQ34550631-1DC521F7-07A3-47C7-9202-9D68A7321D63Q34621641-AAB620A5-41B9-4EAB-A95B-59951391C06CQ34728285-DAFC7EF5-1F6E-41B7-871E-ACE92F856986Q35046497-766DEFF1-E93E-41F3-84B9-8E12254A30A2
P2860
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.
@en
type
label
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.
@en
prefLabel
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.
@en
P2093
P2860
P1433
P1476
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.
@en
P2093
Annette R Atkins
Caroline Wilson
Christopher Liddle
Christopher Scott
Grant D Barish
Jenny E Gunton
Mara H Sherman
Mathias Leblanc
Michael Downes
Mingxiao He
P2860
P304
P356
10.1016/J.CELL.2013.03.028
P407
P577
2013-04-01T00:00:00Z